난소적출 마우스를 이용한 골다공증 개선효과를 나타내는 巴戟天과 肉蓗蓉 熱水 抽出物의 복합 최적 조성 선택 실험
Selection of the Fittest Anti-osteoporotic Mixed Compositions Consist of Morindae Radix and Cistanchis Herba Aqueous Extracts on Ovariectomized Mice
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objectives: To select the optimal ranges showing obvious synergic anti-osteoporotic potential after adjust mixed formula consisted of Morindae Radix (MR) and Cistanchis Herba (CH) as compared with those of each single formula or risedronate sodium (RES) using bilateral ovariectomized (OVX) female mice. Methods: Fourteen groups, total eight sham or 104 OVX mice were selected based on the body weights at 34 days after OVX surgery. After that, 9 types mixed compositions, single formula of MR and CH, and RES were orally administered for 35 days. And we measured changes in body weight and gain, femur weight, bone mineral density (BMD), bone strength (failure load) and mineral content - calcium (Ca) and inorganic phosphorus (IP), osteocalcin contents and bone specific alkaline phosphatase (bALP) activities of all mice. Results: The OVX-induced estrogen-deficient osteoporotic signs were significantly inhibited by 35 days of continuous oral treatment of all treated mice as compared with OVX control mice. Especially, MR:CH 1:3 and 1:1 mixed formula treated mice showed significantly more favorable inhibitory activities against estrogen-deficient osteoporosis symptoms as compared to those of each single formula of MR and CH. Although RES also ameliorated the decreases of the femur BMD, strength and trabecular bone architectures through the inhibited the increases of bone turnover, but they did not critically influenced on the bone formations. Conclusions: The results suggest that MR:CH 1:3 mixed formula showed somewhat lower anti-resorptive effects as compared to those of RES, but they also showed bone formation effects. therefore, it is expected that MR:CH 1:3 mixture will be promising as a potent protective agents for relieving the osteoporosis in menopausal women.
Abstract
Objectives: To select the optimal ranges showing obvious synergic anti-osteoporotic potential after adjust mixed formula consisted of Morindae Radix (MR) and Cistanchis Herba (CH) as compared with those of each single formula or risedronate sodium (RES) using bilateral ovariectomized (OVX) female mice. Methods: Fourteen groups, total eight sham or 104 OVX mice were selected based on the body weights at 34 days after OVX surgery. After that, 9 types mixed compositions, single formula of MR and CH, and RES were orally administered for 35 days. And we measured changes in body weight and gain, femur weight, bone mineral density (BMD), bone strength (failure load) and mineral content - calcium (Ca) and inorganic phosphorus (IP), osteocalcin contents and bone specific alkaline phosphatase (bALP) activities of all mice. Results: The OVX-induced estrogen-deficient osteoporotic signs were significantly inhibited by 35 days of continuous oral treatment of all treated mice as compared with OVX control mice. Especially, MR:CH 1:3 and 1:1 mixed formula treated mice showed significantly more favorable inhibitory activities against estrogen-deficient osteoporosis symptoms as compared to those of each single formula of MR and CH. Although RES also ameliorated the decreases of the femur BMD, strength and trabecular bone architectures through the inhibited the increases of bone turnover, but they did not critically influenced on the bone formations. Conclusions: The results suggest that MR:CH 1:3 mixed formula showed somewhat lower anti-resorptive effects as compared to those of RES, but they also showed bone formation effects. therefore, it is expected that MR:CH 1:3 mixture will be promising as a potent protective agents for relieving the osteoporosis in menopausal women.
참고문헌 (47)
- Sambrook P, "Osteoporosis", Lancet, 367(9527), pp.2010~2018 (2006)
- "2010 National Health Statistics and 2010 Health Behavior and Chronic Disease Statistics"[URL]
- National Osteoporosis Foundation, "Clinician’s guide prevention and treatment of osteoporosis", ~ (2008)
- "Who’s at risk?["[URL]
- The Society of Korean Medicine Obstetrics and Gynecology, "Oriental Obstetrics & Gynecology", pp.252~254 (2016), Euiseongdang publisher
- Prevention and Management of Osteoporosis, "World Health Organization", ~ (2003)
- Korean Society for Bone and Mineral Research, "Physician’s guide for diagnosis & treatment of osteoporosis", ~ (2015)
- Camacho PM, "American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis - 2016", Endocr Pract, 22(4), pp.1~42 (2016)
- Gennari L, "Treatment needs and current options for postmenopausal osteoporosis", Expert Opin Pharmacother, 17(8), pp.1141~1152 (2016)
- Seo MS, "The Review on the Study of Osteoporosis in Korean Medicine Journals", The Journal of Korea CHUNA Manual Medicine for Spine & Nerves, 8(2), pp.67~78 (2013)
- Kim JY, "The Study about the Comparison of Korean-Western Medicine on Osteoporosis", Journal of Oriental Rehabilitation Medicine, 6, pp.293~315 (1996)
- Kim HG, "The study about the comparison of Korean-Western medicine on sin-ju-gol(腎主骨)", The Journal of Korean Oriental Internal Medicine, 12(2), pp.26~29 (1991)
- Lee CH, "The Study of Document on Osteoporosis through Oriental Medicine", Dong-Eui Institute of Oriental Medicine, 4, pp.107~127 (2000)
- National College of Oriental Medicine Common Textbook Compilation Committee, "Herbal medicine(本草學)", pp.594~597 (2008), Yeonglimsa
- Zhang H, "Antioxidant activity and physicochemical properties of an acidic polysaccharide from Morinda officinalis", Int J Biol Macromol, 58, pp.7~12 (2013)
- Wat E, "The protective effect of Herba Cistanches on statin-induced myotoxicity in vitro", J Ethnopharmacol, 190, pp.68~73 (2016)
- Heo J, "Dongeuibogam" (2008), Bubinbooks
- Kang SJ, "Selection of the Optimal Herbal Compositions of Red Clover and Pomegranate according to their Protective Effect against Climacteric Symptoms in Ovariectomized Mice", Nutrients, 8(8), pp.447~ (2016)
- Harris ST, "Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group", JAMA, 282(14), pp.1344~1352 (1999)
- Nam SH, "Topically administered Risedronate shows powerful anti- osteoporosis effect in ovariectomized mouse model", Bone, 50(1), pp.149~155 (2012)
- Shin HD, "Antiosteoporotic effect of Polycan, beta-glucan from Aureobasidium, in ovariectomized osteoporotic mice", Nutrition, 23(11-12), pp.853~860 (2007)
- Joo JH, "A Novel Pyrazole Derivative Protects from Ovariectomy- induced Osteoporosis through the Inhibition of NADPH oxidase", Sci Rep, 6, pp.22389~ (2016)
- Ludbrook J, "Update: Microcomputer Statistics Packages. A personal view", Clin Exp Pharmacol Physiol, 24(3-4), pp.294~296 (1997)
- Levene A, "Pathological factors influencing excision of tumours in the head and neck. Part I", Clin Otolaryngol Allied Sci, 6(2), pp.145~151 (1981)
- Kang SJ, "Fermentation with Aquilariae Lignum enhances the anti- diabetic activity of green tea in type II diabetic db", db mouse, 2014, pp.6(9), 3536~3571
- Choi JS, "Blood glycemia- modulating effects of melanian snail protein hydrolysates in mice with type II diabetes", Int J Mol Med, 39(6), pp.1437~1451 (2017)
- Manolagas SC, "Sex steroids and bone", Recent Prog Horm Res, 57, pp.385~409 (2002)
- Rodan GA, "Therapeutic Approaches to Bone Diseases", Science, 289(5484), pp.1508~1514 (2000)
- MacDonald BR, "Emerging Therapies in Osteoporosis", Best Pract Res Clin Rheumatol, 15(3), pp.483~496 (2001)
- Wu YB, "Antiosteoporotic Activity of Athraquinones from Morinda officinalis on Osteoblasts and Osteoclasts", Molecules, 14(1), pp.573~583 (2009)
- Li TM, "Cistanche deserticola extract increases bone formation in osteoblasts", J Pharm Pharmacol, 64(6), pp.897~907 (2012)
- Xu X, "Therapeutic Effect of Cistanoside A on bone metabolism of ovariectomized mice", Molecules, 22(2), pp.197~ (2017)
- Kang SJ, "Dried pomegranate potentiates anti-osteoporotic and anti-obesity activities of red clover dry extracts in ovariectomized rats", Nutrients, 7(4), pp.2622~2647 (2015)
- Choi JS, "Effect of Polycalcium, a mixture of Polycan and calcium lactate-gluconate in a 1 : 9 weight ratio, on rats with surgery-induced osteoarthritis", Exp Ther Med, 9(5), pp.1780~1790 (2015)
- Park SI, "The Effects of Topical Application of Polycal(a 2 : 98(g", g)Mixture of Polycan and Calcium Gluconate)on Experimental Periodontitis and Alveolar Bone loss in Rats, 2016, pp.21(4), 527~
- Lorden JF, "Behavioral and Endocrinological Effects of Single Injections of Monosodium Glutamate in the Mouse", Neurobehav Toxicol Teratol, 8(5), pp.509~519 (1986)
- Bain SD, "High-dose Estrogen Inhibits Bone Resorption and Stimulates Bone Formation in the Ovariectomized Mouse", J Bone Miner Res, 8(4), pp.435~442 (1993)
- Andersson N, "Repeated in vivo Determinations of Bone Mineral Density During Parathyroid Hormone Treatment in Ovariectomized Mice", J Endocrinol, 170(3), pp.529~537 (2001)
- Yamamoto M, "The Integrin Ligand Echistatin Prevents Bone Loss in Ovariectomized Mice and Rats", Endocrinology, 139(3), pp.1411~1419 (1998)
- Ke HZ, "Long-term treatment of lasofoxifene preserves bone mass and bone strength and dose not adversely affect the uterus in ovariectomized rats", Endocrinology, 145(4), pp.1996~2005 (2004)
- Ederveen AG, "Tibolone, a steroid with a tissue-specific hormonal profile, completely prevents ovariectomy-induced bone loss in sexually mature rats", J Bone Miner Res, 14(11), pp.1963~1970 (1999)
- Ismail F, "Serum bone gla protein and the vitamin D endocrine system in the oophorectomized rat", Endocrinology, 122(2), pp.624~630 (1988)
- Tanaka S, "Acute effects of ovariectomy on wound healing of alveolar bone after maxillary molar extraction in aged rats", Anat Rec, 262(2), pp.203~212 (2001)
- Tarvainen R, "Clodronate Prevents Immobilization Osteopenia in Rats", Acta Orthop Scand, 65(16), pp.643~646 (1994)
- Syed Z, "Bone Densitometry : applications and limitations", J Obstet Gynecol Can, 24(6), pp.476~484 (2002)
- Diez F, "Guidelines for the Diagnosis of Osteoporosis by Densitometric Methods", J Manipulative Physiol Ther, 25(6), pp.403~415 (2002)
- Park JH, "Euiyuksinnongbonchokyung (意譯神農本草經)", pp.4~5 (2014), Sinil seojeok